Forecast for Vaccine Stocks After Coronavirus Pandemic Passes
Stephen Gardner, director at ETF Managers Group, explains why investors shouldn't be rushing to sell vaccine stocks like Moderna or BioNTech even as the spread of COVID-19 slows down.
More Videos
Will Converting Empty Office Buildings Solve New York City's Housing Crisis?
An exclusive look inside NYCs office-to-residence conversion boom and how these ambitious projects may provide a blueprint for addressing housing shortages
Peach & Lily CEO On Going From K‑Beauty Pioneer to 2025’s Skincare Brand of the Year
Alicia Yoon, CEO of Peach & Lily, explores K‑Beauty’s rise, their plant‑powered innovation process & the popularity of the glass skin trend. Watch!
Pharma Stocks Soar Amid Medicaid Cuts and Trump’s Price Pressure — Here’s Why
Amanda Chu of POLITICO reveals how lawmakers are betting millions on pharma stocks even as Trump threatens tariffs and demands steep drug price cuts. Watch!
What You Need to Know Ahead of Potential Record-Breaking Travel For July 4th
Hayley Berg, Hopper’s lead economist, previews soaring summer 2025 travel: record international flights, cheaper fares for Europe & Asia, plus booking hacks.
Debt, Data, and Danger Signs: The State of the U.S. Consumer
NerdWallet Senior Economist Liz Renter shares what she's tracking in economic data, with a focus on U.S. household debt and rising credit card balances. Watch!
WallStreetBets to Wall Street Wisdom: One-on-One with Jaime Rogozinski
Jaime Rogozinski, founder of WallStreetBets and Chief Strategy Officer of Wire Network, breaks down market volatility and options trading.
